SRS Health Revenue and Competitors

Montvale, NJ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SRS Health's estimated annual revenue is currently $13.7M per year.(i)
  • SRS Health's estimated revenue per employee is $140,000

Employee Data

  • SRS Health has 98 Employees.(i)

SRS Health's People

NameTitleEmail/Phone
1
Senior Integration SpecialistReveal Email/Phone
2
Implementation SupervisorReveal Email/Phone
3
Regional Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1360M6231-34%N/A$17.7B
#2
$872.9M4300N/AN/AN/A
#3
$1500M5609-10%$100M$2.2B
#4
$15.5M111-7%$157.5MN/A
#5
$16M1238%N/AN/A
#6
$36.4M2285%N/AN/A
#7
$124.5M6872%N/AN/A
#8
$23.2M154-8%$60.7MN/A
#9
$317.9M15888%$332.6M$1B
#10
$22.3M140N/AN/AN/A
#11
$5.6M48N/AN/AN/A
#12
$306.2M810N/AN/AN/A
#13
$160.3M475N/AN/AN/A
#14
$79.4M4319%$10.7MN/A
#15
$80.3M47627%N/AN/A
#16
$3.5M30-9%N/AN/A
#17
$62.4M344N/AN/AN/A
#18
$48.4M163N/AN/AN/A
#19
$79.8M440-1%N/AN/A
#20
$26.8M168N/AN/AN/A
Add Company

What Is SRS Health?

keywords:N/A

N/A

Total Funding

98

Number of Employees

$13.7M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

SRS Health News

2022-04-20 - Baptist Health South Florida to acquire ZAP-X gyroscopic ...

... Health South Florida (Miami, USA) will acquire the ZAP-X gyroscopic radiosurgery platform for cranial stereotactic radiosurgery (SRS).

2022-04-19 - Baptist Health South Florida to Acquire ZAP Surgical’s ZAP-X Gyroscopic Radiosurgery Platform for Advanced Brain Tumor Treatments

... Baptist Health South Florida, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform for cranial stereotactic radiosurgery (SRS).

2022-04-17 - The Social Robots Are Coming: Preparing for a New Wave of ...

Social robots (SRs) may rise to the challenge. ... In health care applications, SRs act as a social companion and medical assistant to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25M10211%$300M
#2
$18.5M13214%$34M
#3
$34.5M1380%N/A
#4
$24.4M1532%N/A
#5
$48.2M1992%N/A